Research Studies

Marine Omega-3 Fatty Acids and Prevention of Vascular Disease and Cancer

463. EFFECTS OF 24-MONTH SUPPLEMENTATION OF EPA AND DHA ON HIPPOCAMPAL SPONTANEOUS NEUROACTIVITY IN MILD COGNITIVE IMPAIRMENT AND DEMENTIA: A RESTING-STATE FMRI STUDY

Beneficial Interactions Between B Vitamins and Omega‐3 Fatty Acids in the Prevention of Brain Atrophy and of Cognitive Decline in Early Stage Alzheimer's Disease

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Omega-3 polyunsaturated fatty acids improve mitochondrial dysfunction in brain aging--impact of Bcl-2 and NPD-1 like metabolites.

Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer’s Disease: The OmegAD Study

Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial.

A combination of omega-3 fatty acids, folic acid and B-group vitamins is superior at lowering homocysteine than omega-3 alone: A meta-analysis.

Marine Omega-3 Fatty Acids and Prevention of Vascular Disease and Cancer

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment